✦ LIBER ✦

Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: An observational study

✍ Scribed by Lawrence Serfaty; Antoine De Leusse; Olivier Rosmorduc; Benoit Desaint; Jean-Francois Flejou; Olivier Chazouilleres; Renée E. Poupon; Raoul Poupon

Book ID: 111722318
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 170 KB
Volume: 38
Category: Article
ISSN: 0270-9139
DOI: 10.1053/jhep.2003.50311

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunomodulating effect of ursodeoxychol

Immunomodulating effect of ursodeoxycholic acid therapy in patients with primary biliary cirrhosis

✍ D. Kürktschiev; S. Subat; D. Adler; K.-U. Schentke 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Utilization of the Mayo risk score in pa

Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid

✍ Paul Angulo; Keith D. Lindor; Terry M. Therneau; Roberta A. Jorgensen; Michael M 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 720 KB

Combination therapy of bezafibrate and u

Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study

✍ Seiji Nakai; Tsutomu Masaki; Kazutaka Kurokohchi; Akihiro Deguchi; Mikio Nishiok 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 57 KB

Ursodeoxycholic acid therapy plays an im

Ursodeoxycholic acid therapy plays an immunomodulatory and anti-apoptotic role in patients with primary sclerosing cholangitis and primary biliary cirrhosis

✍ M.G. Neuman; P. Angulo; I.M. Malkiewicz; G.G. Katz; R. Jorgensen; Z. Ben-Ari; H. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Pilot study: fenofibrate for patients wi

Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

✍ C. Levy; J. A. Peter; D. R. Nelson; J. Keach; J. Petz; R. Cabrera; V. Clark; R. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Cholesterol-lowering effect of ursodeoxy

Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis

✍ Renée E. Poupon; Khadija Ouguerram; Yves Chrétien; Claudine Verneau; Eveline Esc 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

We have previously shown in a 2-yr controlled trial that hypercholesterolemia, frequent in primary biliary cirrhosis, is lowered by ursodeoxycholic acid (13 to 15 mg daily). To further investigate this effect, we analyzed the influence of long-term ursodeoxycholic acid administration on serum lipids